Advertisement

Levels of High-Density Lipoprotein Cholesterol are Associated With Biomarkers of Inflammation in Patients With Acute Coronary Syndrome

Published:September 10, 2015DOI:https://doi.org/10.1016/j.amjcard.2015.09.009
      Pathologic conditions associated with inflammation show an inverse correlation between high-density lipoprotein cholesterol (HDL-C) and inflammatory biomarker levels. Our aim was to investigate, in patients with acute coronary syndrome (ACS), whether very low HDL-C levels are associated with inflammatory biomarkers. In a cross-sectional study, we included 6,134 patients with ACS; they were classified as having very low (<30 mg/dl), low (30 to 39.9 mg/dl), and normal HDL-C (≥40 mg/dl) levels. We analyzed the association of different categories of HDL-C levels with serum levels of inflammatory biomarkers, high-sensitivity C-reactive protein (hs-CRP), albumin, and white blood cell count at admission. Overall, 18.5% of patients had very low HDL-C levels. Patients with very low HDL-C levels, compared to patients with low or normal HDL-C levels, had the highest hs-CRP (median 17.8 [interquartile range 7.2 to 54.5] vs 12.6 [5.6 to 33.9] vs 12.0 [5.4 to 36.9] mg/L, respectively, p <0.001) and the lowest albumin levels (median 3.6 [IQR 3.3 to 4.0] vs 3.8 [3.5 to 4.0] vs 3.8 [3.5 to 4.1] g/dl, respectively, p <0.001). White blood cell count did not differ significantly (p = 0.40). The multivariate analysis showed that albumin ≤3.5 g/dl (odds ratio 2.16, 95% confidence interval 1.88 to 2.49, p <0.001) and hs-CRP ≥10 mg/L (odds ratio 1.35, 95% confidence interval 1.17 to 1.55, p <0.001) were independent predictors of very low HDL-C levels. Patients with very low HDL-C levels had the highest inhospital mortality rates compared with the other groups. In conclusion, in patients with ACS, hs-CRP and serum albumin were associated independently with very low HDL-C levels.
      To read this article in full you will need to make a payment

      References

        • Borba E.F.
        • Bonfá E.
        Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.
        Lupus. 1997; 6: 533-539
        • Robertson J.
        • Peters M.J.
        • McInnes I.B.
        • Sattar N.
        Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm.
        Nat Rev Rheumatol. 2013; 9: 513-523
        • Cabana V.G.
        • Gidding S.S.
        • Getz G.S.
        • Chapman J.
        • Shulman S.T.
        Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease.
        Pediatr Res. 1997; 42: 651-655
        • van Halm V.P.
        • van Denderen J.C.
        • Peters M.J.
        • Twisk J.W.
        • van der Paardt M.
        • van der Horst-Bruinsma I.E.
        • van de Stadt R.J.
        • de Koning M.H.
        • Dijkmans B.A.
        • Nurmohamed M.T.
        Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis.
        Ann Rheum Dis. 2006; 65: 1473-1477
        • Gordon B.R.
        • Parker T.S.
        • Levine D.M.
        • Saal S.D.
        • Wang J.C.
        • Sloan B.J.
        • Barie P.S.
        • Rubin A.L.
        Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients.
        Crit Care Med. 2001; 29: 1563-1568
        • Gordon B.R.
        • Parker T.S.
        • Levine D.M.
        • Saal S.D.
        • Wang J.C.
        • Sloan B.J.
        • Barie P.S.
        • Rubin A.L.
        Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia.
        Crit Care Med. 1996; 24: 584-589
        • Haas M.J.
        • Mooradian A.D.
        Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease.
        Diabetes Metab Res Rev. 2010; 26: 90-99
        • Cannon C.P.
        • Battler A.
        • Brindis R.G.
        • Cox J.L.
        • Ellis S.G.
        • Every N.R.
        • Flaherty J.T.
        • Harrington R.A.
        • Krumholz H.M.
        • Simoons M.L.
        • Van De Werf F.J.
        • Weintraub W.S.
        • Mitchell K.R.
        • Morrisson S.L.
        • Brindis R.G.
        • Anderson H.V.
        • Cannom D.S.
        • Chitwood W.R.
        • Cigarroa J.E.
        • Collins-Nakai R.L.
        • Ellis S.G.
        • Gibbons R.J.
        • Grover F.L.
        • Heidenreich P.A.
        • Khandheria B.K.
        • Knoebel S.B.
        • Krumholz H.L.
        • Malenka D.J.
        • Mark D.B.
        • Mckay C.R.
        • Passamani E.R.
        • Radford M.J.
        • Riner R.N.
        • Schwartz J.B.
        • Shaw R.E.
        • Shemin R.J.
        • Van Fossen D.B.
        • Verrier E.D.
        • Watkins M.W.
        • Phoubandith D.R.
        • Furnelli T.
        American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee).
        J Am Coll Cardiol. 2001; 38: 2114-2130
        • Gabay C.
        • Kushner I.
        Acute-phase proteins and other systemic responses to inflammation.
        N Engl J Med. 1999; 340: 448-454
        • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
        Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
        Circulation. 2002; 106: 3143-3421
        • Heeschen C.
        • Hamm C.W.
        • Bruemmer J.
        • Simoons M.L.
        Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial.
        J Am Coll Cardiol. 2000; 35: 1535-1542
        • Furman M.I.
        • Gore J.M.
        • Anderson F.A.
        • Budaj A.
        • Goodman S.G.
        • Avezum A.
        • López-Sendón J.
        • Klein W.
        • Mukherjee D.
        • Eagle K.A.
        • Dabbous O.H.
        • Goldberg R.J.
        • GRACE Investigators
        Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE).
        Am Heart J. 2004; 147: 42-48
        • Oduncu V.
        • Erkol A.
        • Karabay C.Y.
        • Kurt M.
        • Akgün T.
        • Bulut M.
        • Pala S.
        • Kirma C.
        The prognostic value of serum albumin levels on admission in patients with acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
        Coron Artery Dis. 2013; 24: 88-94
        • Roe M.T.
        • Ou F.S.
        • Alexander K.P.
        • Newby L.K.
        • Foody J.M.
        • Gibler W.B.
        • Boden W.E.
        • Ohman E.M.
        • Smith Jr., S.C.
        • Peterson E.D.
        Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes.
        Eur Heart J. 2008; 298: 2480-2488
        • Acharjee S.
        • Roe M.T.
        • Amsterdam E.A.
        • Holmes D.N.
        • Boden W.E.
        Relation of admission high-density lipoprotein cholesterol level and in-hospital mortality in patients with acute non-ST segment elevation myocardial infarction (from the National Cardiovascular Data Registry).
        Am J Cardiol. 2013; 112: 1057-1062
        • Pitt B.
        • Loscalzo J.
        • Ycas J.
        • Raichlen J.S.
        Lipid levels after acute coronary syndromes.
        J Am Coll Cardiol. 2008; 51: 1440-1445
        • Navab M.
        • Berliner J.A.
        • Subbanagounder G.
        • Hama S.
        • Lusis A.J.
        • Castellani L.W.
        • Reddy S.
        • Shih D.
        • Shi W.
        • Watson A.D.
        • Van Lenten B.J.
        • Vora D.
        • Fogelman A.M.
        HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.
        Arterioscler Thromb Vasc Biol. 2001; 21: 481-488
        • Akgün S.
        • Ertel N.H.
        • Mosenthal A.
        • Oser W.
        Postsurgical reduction of serum lipoproteins: interleukin-6 and the acute-phase response.
        J Lab Clin Med. 1998; 131: 103-108
        • Bentz M.H.
        • Magnette J.
        Hypocholesterolemia during the acute phase of an inflammatory reaction of infectious origin. 120 cases.
        Rev Med Interne. 1998; 19: 168-172
        • Fraunberger P.
        • Pilz G.
        • Cremer P.
        • Werdan K.
        • Walli A.K.
        Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock.
        Shock. 1998; 10: 359-363
        • Chien J.Y.
        • Jerng J.S.
        • Yu C.J.
        • Yang P.C.
        Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis.
        Crit Care Med. 2005; 33: 1688-1693
        • Schiele F.
        • Meneveau N.
        • Seronde M.F.
        • Chopard R.
        • Descotes-Genon V.
        • Dutheil J.
        • Bassand J.P.
        • Reseau de Cardiologie de Franche Comte
        C-reactive protein improves risk prediction in patients with acute coronary syndromes.
        Eur Heart J. 2010; 31: 290-297
        • Van Lenten B.J.
        • Reddy S.T.
        • Navab M.
        • Fogelman A.M.
        Understanding changes in high density lipoproteins during the acute phase response.
        Arterioscler Thromb Vasc Biol. 2006; 26: 1687-1688
        • Navab M.
        • Anantharamaiah G.M.
        • Fogelman A.M.
        The role of high-density lipoprotein in inflammation.
        Trends Cardiovasc Med. 2005; 15: 158-161
        • Alwaili K.
        • Bailey D.
        • Awan Z.
        • Bailey S.D.
        • Ruel I.
        • Hafiane A.
        • Krimbou L.
        • Laboissiere S.
        • Genest J.
        The HDL proteome in acute coronary syndromes shifts to an inflammatory profile.
        Biochim Biophys Acta. 2012; 1821: 405-415
        • Morton A.C.
        • Rothman A.M.
        • Greenwood J.P.
        • Gunn J.
        • Chase A.
        • Clarke B.
        • Hall A.S.
        • Fox K.
        • Foley C.
        • Banya W.
        • Wang D.
        • Flather M.D.
        • Crossman D.C.
        The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study.
        Eur Heart J. 2015; 36: 377-384
        • Schwartz G.G.
        • Olsson A.G.
        • Abt M.
        • Ballantyne C.M.
        • Barter P.J.
        • Brumm J.
        • Chaitman B.R.
        • Holme I.M.
        • Kallend D.
        • Leiter L.A.
        • Leitersdorf E.
        • McMurray J.J.
        • Mundl H.
        • Nicholls S.J.
        • Shah P.K.
        • Tardif J.C.
        • Wright R.S.
        • dal-OUTCOMES Investigators
        Effects of dalcetrapib in patients with a recent acute coronary syndrome.
        N Engl J Med. 2012; 367: 2089-2099
        • Tehrani D.M.
        • Gardin J.M.
        • Yanez D.
        • Hirsch C.H.
        • Lloyd-Jones D.M.
        • Stein P.K.
        • Wong N.D.
        Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: Cardiovascular Health Study.
        Atherosclerosis. 2013; 231: 246-251